Eyebrain Medical yesterday filed an amendment to its SEC Form D to confirm the sale of more than $23.8 million in an equity offering. The offering is slated to collect just shy of $24 million, leaving the Costa Mesa, Calif.-based company with $180,026 remaining to be sold. Eyebrain Medical made the first sale on July […]
eyeBrain Medical
eyeBrain Medical pulls in $6m for NeuroLens chronic headache treatment
Hybrid neurological and ophthalmological company eyeBrain Medical raised $6 million in a new round of equity financing for its chronic severe headache treatment technology. The company is aiming to treat what it calls ‘eyegraines’, or visual misalignments between images from both eyes that eyeBrain says can over stimulate the trigeminal nerve in the brain and […]
